Skip to main content

Table 2 The chi-square test of the relation between risk score and clinical features in ICGC and GSE14520 cohort

From: Risk predictive model based on three immune-related gene pairs to assess prognosis and therapeutic sensitivity for hepatocellular carcinoma

Clinical features

ICGC, n = 231

GSE14520, n = 242

High risk

Low risk

P

High risk

Low risk

P

Survival status

  

0.04

  

0.04

 Survived

43

146

 

12

134

 

 Died

16

26

 

16

80

 

Age

  

0.63

  

0.17

 ≥ 60 years

49

138

 

3

47

 

 < 60 years

10

34

 

25

167

 

Sex

  

0.84

  

0.12

 Male

44

126

 

27

184

 

 Female

15

46

 

1

30

 

Stage

  

< 0.001

  

0.08

 I–II

25

116

 

18

156

 

 III–IV

34

56

 

10

41

 

 x

0

0

 

0

17

 

Histological grade

  

< 0.01

   

 G1–2

30

128

    

 G3–4

21

33

    

 Gx

8

11

    

Cirrhosis status

     

0.37

 No cirrhosis

   

1

18

 

 Cirrhosis

   

27

196

 

Recurrence status

     

0.19

 No recurrence

   

9

97

 

 Recurrence

   

19

117

 

Hepatitis status

     

0.23

 Hepatitis B

   

27

191

 

 No hepatitis

   

1

23

 
  1. The cases with “Gx” and stage “x” were excluded from the chi-square test